It’s not unusual for someone to take several different medications at the same time. Yet pharmaceutical companies seldom study the effects of taking drugs in combination. Russ Altman, a Stanford professor of bioengineering, genetics and medicine, is pioneering the use of data mining to identify adverse as well as beneficial interactions. getAbstract believes his noteworthy discovery will interest members of the medical and technology communities.
In this summary, you will learn
- Why drug interactions are difficult to study,
- How researchers mined data to discover the combined effect of paroxetine and pravastatin on glucose, and
- How data science will identify adverse effects as well as beneficial treatments.
About the Speaker
Russ Altman is a professor of bioengineering, genetics and medicine at Stanford University.